Beranda › Penyakit Endokrin › California
Uji klinis Penyakit Endokrin di California
6 studi untuk Penyakit Endokrin mencari peserta di lokasi di California.
Teks studi resmi (Bahasa Inggris)
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
- Ascendis Pharma Investigational Site, Palo Alto
- Ascendis Pharma Investigational Site, Sacramento
Menerima pesertaFase 3
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07221851A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- San Fernando Valley Health Institute, Canoga Park
- Headlands Research California, LLC, Escondido
- ImmuniMet, LLC, Modesto
- dan 4 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07595549Understanding New Cachexia Subtypes Through Observational Epidemiological Research
- Kaiser Permanente Northern California, Pleasanton
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07776353Study of BHV-1300 in Graves' Disease
- Site-103, South Gate
Menerima pesertaFase 1
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT06980649A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- St Joseph Heritage Healthcare, Santa Rosa
Menerima pesertaFase 1/2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 27 Mei 2026 · NCT03093116Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
- Limb Preservation Platform Inc, Fresno
- Angel City Research, Los Angeles
- Clemente Clinical Research, Los Angeles
- dan 1 lainnya
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Feb 2025 · NCT06681428Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.